This is an information message
We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.
The recent brouhaha about somebody “dropping the ball” with regard to getting 10 million doses of the Pfizer vaccine by end January hasn’t gotten the public attention it deserves. Maybe this is because government authorities—the executive, the…
MANILA, Philippines — After its withdrawal of application for the conduct of COVID-19 shots clinical trials in the country, the next step for British vaccine developer AstraZeneca for its vaccines to be able to be used in…
MANILA, Philippines — Over 100 million Filipinos are estimated to be vaccinated against the coronavirus disease 2019 (COVID-19) if each vaccine that the government would buy is priced at P600, Senator Sonny Angara said Thursday. The budget…
MANILA, Philippines — Three developers of vaccines against COVID-19 have passed the review of the ethics board, advancing their applications to conduct clinical trials in the country, the Department of Health (DOH) said Monday. Belgium’s Janssen Pharmaceutical,…
MANILA, Philippines — The Philippine government, together with local private companies, will sign a tripartite agreement with British drugmaker AstraZeneca on Friday for the purchase of its COVID-19 vaccine. The country’s vaccine czar Secretary Carlito Galvez Jr.…
LONDON — Oxford University announced Saturday it was resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca, a move that comes days after the study was suspended following a reported side-effect in…
LONDON — A woman who received an experimental coronavirus vaccine developed severe neurological symptoms that prompted a pause in testing, a spokesman for drugmaker AstraZeneca said Thursday. The study participant in late-stage testing reported symptoms consistent with…
LONDON — A woman who received an experimental coronavirus vaccine developed severe neurological symptoms that prompted a pause in testing, a spokesman for drugmaker AstraZeneca said Thursday. The study participant in late-stage testing reported symptoms consistent with…
AstraZeneca Plc said on Monday it began to enroll 30,000 participants aged above 18 in a late-stage study to evaluate its COVID-19 vaccine candidate, AZD1222. Participants are being randomized to receive two doses of either AZD1222 or…
Pharma giant AstraZeneca said Tuesday it had begun a clinical trial of a drug designed to both prevent infection and treat people with COVID-19, with the first volunteers receiving doses. The drug, known as AZD7442, is a…
PARIS — A coronavirus vaccine being developed by the University of Oxford and AstraZeneca should be available globally “at cost price” by year end, the firm’s director general said on Tuesday. “Our objective is to bring…
This is an information message
We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.